<HashMap><database>biostudies-other</database><scores/><additional><omics_type>Unknown</omics_type><volume>22</volume><submitter>Lucian Smith</submitter><journal>Pharmaceutical research</journal><pagination>1589-1596</pagination><species>Unknown</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/MODEL1907290001</full_dataset_link><repository>biostudies-other</repository><additional_accession>16180117</additional_accession><pubmed_authors>Tung Nguyen</pubmed_authors><pubmed_authors>Lucian Smith</pubmed_authors><pubmed_authors>Johannes Meyer</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mager2005 - Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition</name><description>&lt;notes xmlns="http://www.sbml.org/sbml/level2/version4">      &lt;body xmlns="http://www.w3.org/1999/xhtml">        &lt;pre>This model was developed with the aim of constructing an equilibrium model of the pharmacokinetic behaviour of a drug exhibiting target-mediated drug disposition (TMDD). TMDD involves the inclusion of drug-target interactions within a pharmacokinetic description, something which is usually considered negligible and subsequently excluded. Two approaches were used, one of which involved a quasi-equilibrium method to describe the kinetics of TMDD.&lt;/pre>      &lt;/body>    &lt;/notes></description><dates><release>2019-07-29T00:00:00Z</release><modification>2025-07-15T09:52:43.936Z</modification><creation>2025-03-29T20:59:39.154Z</creation></dates><accession>MODEL1907290001</accession><cross_references><sbo>SBO:0000177</sbo><sbo>SBO:0000180</sbo><sbo>SBO:0000179</sbo><biomodels___db>BIOMD0000000765</biomodels___db><pubmed>16180117</pubmed><pubmed>11999290</pubmed><ncit>C79370</ncit><ncit>C16353</ncit><ncit>C15299</ncit><ncit>C12801</ncit><ncit>C18106</ncit><chebi>CHEBI:23888</chebi><mamo>MAMO_0000046</mamo><go>GO:0043235</go><go>GO:0031623</go><go>GO:0006412</go><taxonomy>1758</taxonomy></cross_references></HashMap>